- Report
- June 2023
- 186 Pages
Global
From €5225EUR$5,500USD£4,481GBP
- Report
- March 2024
- 191 Pages
Global
From €3205EUR$3,374USD£2,749GBP
€3562EUR$3,749USD£3,054GBP
- Report
- March 2024
- 196 Pages
Global
From €3205EUR$3,374USD£2,749GBP
€3562EUR$3,749USD£3,054GBP
- Report
- September 2023
- 140 Pages
Global
From €5653EUR$5,950USD£4,847GBP
- Report
- May 2024
- 92 Pages
Global
From €5320EUR$5,600USD£4,562GBP
- Report
- May 2024
- 88 Pages
Global
From €5320EUR$5,600USD£4,562GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- February 2024
- 250 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- January 2024
- 257 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- December 2023
- 200 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- September 2023
- 190 Pages
Global
From €2366EUR$2,490USD£2,028GBP
- Report
- October 2023
- 189 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Report
- April 2024
- 183 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Report
- March 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,381GBP
- Report
- January 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,381GBP
- Report
- December 2023
- 212 Pages
Global
€4745EUR$4,995USD£4,069GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4703EUR$4,950USD£4,032GBP
Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more